Effect of thrombelastography on timing of coronary artery bypass grafting

Experimental and Therapeutic Medicine

Volumn 16, Issue 2, 2018, Pages 579-584

  Yang, Zhiyuan ^a   Xie, Zhouliang ^a   Pei, Xueliang ^a   Quan, Xiaoqiang ^a   Feng, Deguang ^a  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Coronary artery bypass grafting; Surgical timing; Thrombelastography

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; CLOPIDOGREL; H 10940218; H 20123155; HEPARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DUAL ANTIPLATELET THERAPY; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; INCUBATION TIME; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPERATION DURATION; PERIOPERATIVE PERIOD; SURGICAL MORTALITY; THORACOTOMY; THORAX DRAINAGE; THROMBOCYTE FUNCTION; THROMBOELASTOGRAPHY; TIME TO TREATMENT;

EID: 85049122114     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2018.6202     Document Type: Article

References (20)

1. Roffi M, Gencer B, Storey RF, Andreotti F and Patrono C: Clinical perspectives and pearls from the 2015 ESC NSTE-ACS guidelines. Curr Cardiol Rep 18: 48, 2016.
2. Yanagawa B, Ruel M, Bonneau C, Lee MM, Chung J, Al Shouli S, Fagan A, Al Khalifa A, White CW, Yamashita MH, et al: Dual antiplatelet therapy use by Canadian cardiac surgeons. J Thorac Cardiovasc Surg 150: 1548-1554.e3, 2015.
3. Barbieri L, Pergolini P, Verdoia M, Rolla R, Nardin M, Marino P, Bellomo G, Suryapranata H and De Luca G; Novara Atherosclerosis Study Group (NAS): Platelet reactivity in patients with impaired renal function receiving dual antiplatelet therapy with clopidogrel or ticagrelor. Vascul Pharmacol 79: 11-15, 2016.
4. Janssen PWA, Claassens DMF, Willemsen LM, Bergmeijer TO, Klein P and Ten Berg JM: Perioperative management of antiplatelet treatment in patients undergoing isolated coronary artery bypass grafting in Dutch cardiothoracic centres. Neth Heart J 25: 482-489, 2017.
5. Pilgrim T and Windecker S: Antiplatelet therapy for secondary prevention of coronary artery disease. Heart 100: 1750-1756, 2014.
6. Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, et al: 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg 152: 1243-1275, 2016.
7. van Diepen S, Fuster V, Verma S, Hamza TH, Siami FS, Goodman SG and Farkouh ME: Dual antiplatelet therapy versus aspirin monotherapy in diabetics with multivessel disease undergoing CABG: FREEDOM insights. J Am Coll Cardiol 69: 119-127, 2017.
8. Verma S, Goodman SG, Mehta SR, Latter DA, Ruel M, Gupta M, Yanagawa B, Al-Omran M, Gupta N, Teoh H, et al: Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trials. BMC Surg 15: 112, 2015.
9. Cheng JW: Ticagrelor: Oral reversible P2Y(12) receptor antagonist for the management of acute coronary syndromes. Clin Ther 34: 1209-1220, 2012.
10. Karon BS, Tolan NV, Koch CD, Wockenfus AM, Miller RS, Lingineni RK, Pruthi RK, Chen D and Jaffe AS: Precision and reliability of 5 platelet function tests in healthy volunteers and donors on daily antiplatelet agent therapy. Clin Chem 60: 1524-1531, 2014.
11. Tantry US, Bonello L, Aradi D, Price MJ, Jeong YH, Angiolillo DJ, Stone GW, Curzen N, Geisler T, Ten Berg J, et al: Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 62: 2261-2273, 2013.
12. Bomb R, Oliphant CS and Khouzam RN: Dual antiplatelet therapy after coronary artery bypass grafting in the setting of acute coronary syndrome. Am J Cardiol 116: 148-154, 2015.
13. Fitchett D, Eikelboom J, Fremes S, Mazer D, Singh S, Bittira B, Brister S, Graham J, Gupta M, Karkouti K, et al: Dual antiplatelet therapy in patients requiring urgent coronary artery bypass grafting surgery: A position statement of the Canadian Cardiovascular Society. Can J Cardiol 25: 683-689, 2009.
14. Dias JD, Norem K, Doorneweerd DD, Thurer RL, Popovsky MA and Omert LA: Use of thromboelastography (TEG) for detection of new oral anticoagulants. Arch Pathol Lab Med 139: 665-673, 2015.
15. James K, Bertoja E, O'Beirne J and Mallett S: Use of thromboelastography PlateletMapping to monitor antithrombotic therapy in a patient with Budd-Chiari syndrome. Liver Transpl 16: 38-41, 2010.
16. Ramakrishna H, Gutsche JT, Patel PA, Evans AS, Weiner M, Morozowich ST, Gordon EK, Riha H, Bracker J, Ghadimi K, et al: The year in cardiothoracic and vascular anesthesia: Selected highlights from 2016. J Cardiothorac Vasc Anesth 31: 1-13, 2017.
17. Hansson EC, Malm CJ, Hesse C, Hornestam B, Dellborg M, Rexius H and Jeppsson A: Platelet function recovery after ticagrelor withdrawal in patients awaiting urgent coronary surgery. Eur J Cardiothorac Surg 51: 633-637, 2017.
18. Tang XF, Han YL, Zhang JH, Wang J, Zhang Y, Xu B, Gao Z, Qiao SB, Chen J, Wu Y, et al: Comparing of light transmittance aggregometry and modified thrombelastograph in predicting clinical outcomes in Chinese patients undergoing coronary stenting with clopidogrel. Chin Med J (Engl) 128: 774-779, 2015.
19. Yao Y, Zhang JH, Tang XF, He C, Ma YL, Xu JJ, Song Y, Liu R, Meng XM, Song L, et al: Head to head comparison of two point-of-care platelet function tests used for assessment of on-clopidogrel platelet reactivity in Chinese acute myocardial infarction patients undergoing percutaneous coronary intervention. Chin Med J (Engl) 129: 2269-2274, 2016.
20. Bochsen L, Wiinberg B, Kjelgaard-Hansen M, Steinbrüchel DA and Johansson PI: Evaluation of the TEG platelet mapping assay in blood donors. Thromb J 5: 3, 2007.